An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants
Status:
Completed
Trial end date:
2021-01-04
Target enrollment:
Participant gender:
Summary
A Randomized double blind, placebo controlled study of BMS-986259 to evaluate the safety and
effectiveness of the drug amongst different conditions and populations.